These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5885130)

  • 21. Different H-2 antigens expressed on two tumors derived from one BALB/c mouse.
    Garrido F; Perez M; Iványi P; Schirrmacher V
    Transplant Proc; 1981 Dec; 13(4):1824-7. PubMed ID: 7330970
    [No Abstract]   [Full Text] [Related]  

  • 22. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunologic reactivity of mice with the ascitic form of Ehrlich carcinoma].
    Botev B; Markholev L
    Biull Eksp Biol Med; 1969 Dec; 68(12):70-1. PubMed ID: 5382331
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation of a factor or factors with potent immunifacient properties from Ehrlich ascites carcinoma cells.
    Van Roy M
    Arzneimittelforschung; 1969 Aug; 19(8):1169-71. PubMed ID: 5820280
    [No Abstract]   [Full Text] [Related]  

  • 25. Preimmunization with BCG vaccine prolongs survival of tumour infected host.
    Ray PK; Poduval TB
    Indian J Exp Biol; 1978 Sep; 16(9):1023-5. PubMed ID: 721151
    [No Abstract]   [Full Text] [Related]  

  • 26. Demonstration of a reaction between immunocytes and tumor cells.
    Wrba H; Reider C
    Boll Ist Sieroter Milan; 1971; 50(4):329-33. PubMed ID: 5170764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the transfer of resistance to tumor growth in tumor-bearing animals].
    Obayashi T
    Kumamoto Igakkai Zasshi; 1966 Jan; 40(1):49-64. PubMed ID: 5953549
    [No Abstract]   [Full Text] [Related]  

  • 28. Esters of chlorohydroxyacetone in chemotherapy of murine tumors.
    Babiarz-Tracy P; McCarthy D; Simon P; Burlingham WJ; Fondy TP
    Cancer Res; 1980 Sep; 40(9):3274-80. PubMed ID: 7427941
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
    Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T
    Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohabitation with a sick cage mate: effects on ascitic form of Ehrlich tumor growth and macrophage activity.
    Alves GJ; Vismari L; Palermo-Neto J
    Neuroimmunomodulation; 2007; 14(6):297-303. PubMed ID: 18349552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental study on local immunochemotherapy].
    Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccine.
    Chung MA; Luo Y; O'Donnell M; Rodriguez C; Heber W; Sharma S; Chang HR
    Cancer Res; 2003 Mar; 63(6):1280-7. PubMed ID: 12649188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "In vitro" interrelations BCG--Ehrlich carcinoma cells.
    Piţur I; Ionescu MD; Ciufecu E; Krohmalnic G; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):167-74. PubMed ID: 6756341
    [No Abstract]   [Full Text] [Related]  

  • 35. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG; Bikhunov VL; Zagoruĭko EE
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of sensitization and delayed hypersensitivity reaction on tumor growth in mice].
    Polushkin BV; Gordienko SM
    Vopr Onkol; 1980; 26(7):51-6. PubMed ID: 7405105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.